Overview

Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)

Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of Zofin for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Organicell Regenerative Medicine